Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yumiko Sugiyama, Kaoru Minegishi, Naoki Hamada, Hideto Nagai, Yuko Tatekabe, Naomi Tsuchida, Yutaro Soejima, Yosuke Kunishita, Daiga Kishimoto, Hiroto Nakano, Reikou Kamiyama, Maasa Tamura, Ryusuke Yoshimi, Yukiko Asami, Yohei Kirino, Atsuhisa Ueda & Hideaki Nakajima. (2017) Successful treatment of a patient with refractory haemophagocytic syndrome in systemic lupus erythematosus with mycophenolate mofetil. Modern Rheumatology Case Reports 1:2, pages 79-83.
Read now
Read now
Marta Mosca, Chiara Tani, Maria Elena Filice, Linda Carli, Andrea Delle Sedie, Sabrina Vagnani, Alessandra Della Rossa, Chiara Baldini & Stefano Bombardieri. (2015) TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review. Modern Rheumatology 25:4, pages 642-645.
Read now
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo. (2014) Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opinion on Drug Safety 13:5, pages 649-661.
Read now
Read now
Articles from other publishers (11)
Yi Guo, Ke Hu, Yuxuan Li, Chanjun Lu, Ken Ling, Chuanqi Cai, Weici Wang & Dawei Ye. (2022) Targeting TNF-α for COVID-19: Recent Advanced and Controversies. Frontiers in Public Health 10.
Crossref
Crossref
Leonardo Rivera-Rodriguez, Edwin Pardo-Díaz, Sarbelio Moreno-Espinosa, Selma Scheffler-Mendoza, Marco A. Ruiz-Ontiveros, Luis Martin Garrido-García, Andrea Iglesias-Amaya & Marco A. Yamazaki-Nakashimada. (2021) Use of Infliximab in the Treatment of Macrophage Activation Syndrome Complicating Kawasaki Disease. Journal of Pediatric Hematology/Oncology 43:3, pages e448-e451.
Crossref
Crossref
Sunjoo Kim, Aeri Kim & Jeong Ok Hah. (2020) Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Syndrome in a Child: A Successful Treatment with the BFM-NHL-90 Protocol. Clinical Pediatric Hematology-Oncology 27:2, pages 129-133.
Crossref
Crossref
Pierre-Edouard Gavand, Ilaria Serio, Laurent Arnaud, Nathalie Costedoat-Chalumeau, Julien Carvelli, Antoine Dossier, Olivier Hinschberger, Luc Mouthon, Véronique Le Guern, Anne-Sophie Korganow, Vincent Poindron, Clément Gourguechon, Christian Lavigne, François Maurier, Guylaine Labro, Marie Heymonet, Matthieu Artifoni, Amélie Brabant Viau, Cristophe Deligny, Thomas Sene, Louis Terriou, Jean Sibilia, Alexis Mathian, Coralie Bloch-Queyrat, Claire Larroche, Zahir Amoura & Thierry Martin. (2017) Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients. Autoimmunity Reviews 16:7, pages 743-749.
Crossref
Crossref
H Takahashi, H Tsuboi, I Kurata, H Takahashi, S Inoue, H Ebe, M Yokosawa, S Hagiwara, T Hirota, H Asashima, S Kaneko, H Kawaguchi, Y Kurashima, H Miki, N Umeda, Y Kondo, H Ogishima, T Suzuki, I Matsumoto & T Sumida. (2014) Predictors of the response to treatment in acute lupus hemophagocytic syndrome. Lupus 24:7, pages 659-668.
Crossref
Crossref
Josefina Cortés-Hernández, Natalia Egri, Miquel Vilardell-Tarrés & Josep Ordi-Ros. (2015) Etanercept in refractory lupus arthritis: An observational study. Seminars in Arthritis and Rheumatism 44:6, pages 672-679.
Crossref
Crossref
Alfonso Torres Jim?nez, Eunice Sol?s Vallejo, Maritza Zeferino Cruz, Adriana C?spedes Cruz & Berenice S?nchez Jara. (2014) Macrophage Activation Syndrome as the Initial Manifestation of Severe Juvenile Onset Systemic Lupus Erythematosus. Favorable Response to Cyclophosphamide. Reumatolog?a Cl?nica (English Edition) 10:5, pages 331-335.
Crossref
Crossref
Alfonso Torres Jim?nez, Eunice Sol?s Vallejo, Maritza Zeferino Cruz, Adriana C?spedes Cruz & Berenice S?nchez Jara. (2014) S?ndrome de activaci?n de macr?fago como manifestaci?n inicial de lupus eritematoso sist?mico severo de inicio juvenil. Respuesta favorable a ciclofosfamida. Reumatolog?a Cl?nica 10:5, pages 331-335.
Crossref
Crossref
Yo Ueda, Hiroyuki Yamashita, Yuko Takahashi, Hiroshi Kaneko, Toshikazu Kano & Akio Mimori. (2013) Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review. Clinical Rheumatology 33:2, pages 281-286.
Crossref
Crossref
Piotr Buda, Piotr Gietka, Beata Kołodziejczyk, Lidia Rutkowska-Sak & Janusz Książyk. (2014) Leczenie biologiczne we wtórnych zespołach hemofagocytarnych. Przegląd piśmiennictwa i opis przypadku zespołu aktywacji makrofagów w przebiegu leczenia etanerceptem układowej postaci młodzieńczego idiopatycznego zapalenia stawów. Pediatria Polska 89:1, pages 39-47.
Crossref
Crossref
Jaime Calvo-Alén, Lucía Silva-Fernández, Eduardo Úcar-Angulo, José María Pego-Reigosa, Alejandro Olivé, Carmen Martínez-Fernández, Víctor Martínez-Taboada, José Luis Marenco, Estíbaliz Loza, Javier López-Longo, Juan Jesús Gómez-Reino, María Galindo-Izquierdo, Antonio Fernández-Nebro, María José Cuadrado, María Ángeles Aguirre-Zamorano, Antonio Zea-Mendoza & Íñigo Rúa-Figueroa. (2013) SER Consensus Statement on the Use of Biologic Therapy for Systemic Lupus Erythematosus. Reumatología Clínica (English Edition) 9:5, pages 281-296.
Crossref
Crossref